Key Takeaways
- AMD (AMD) shares surged after beating Q1 earnings estimates with an adjusted EPS of $1.37 and providing strong Q2 revenue guidance of up to $11.50 billion.
- Anthropic has committed to spending $200 billion on Google’s cloud infrastructure and chips, marking a massive escalation in the AI arms race.
- Apple (AAPL) reached a $250 million settlement over a lawsuit involving delays to its "AI Siri" features, according to the Financial Times.
- Geopolitical tensions escalated in the Strait of Hormuz as the U.S. placed military security on commercial ships following reports of maritime incidents and Iranian accusations against the UAE.
- Major U.S. indices closed higher, with the Nasdaq leading gains at 1.03% as investors processed a heavy wave of corporate earnings.
Tech and AI: AMD Beats, Anthropic’s Massive Spend, and Apple Settles
Advanced Micro Devices (AMD) reported strong first-quarter results, posting adjusted EPS of $1.37 on revenue of $10.25 billion, both exceeding analyst expectations. The company’s outlook for the second quarter was particularly bullish, forecasting revenue between $10.90 billion and $11.50 billion, well above the $10.52 billion estimate. Investors reacted positively to the guidance, which suggests continued robust demand for AI-capable data center hardware.
In a landmark deal for the AI sector, Anthropic has reportedly committed to spending $200 billion on Alphabet Inc. (GOOGL) cloud services and chips. This massive investment underscores the capital-intensive nature of generative AI development. Simultaneously, Alphabet (GOOGL) filed for a six-part notes offering totaling up to €9 billion to bolster its financial flexibility.
Apple (AAPL) has moved to resolve legal headwinds by agreeing to a $250 million settlement regarding the delayed rollout of its upgraded "AI Siri" capabilities. The lawsuit had alleged that the company misled shareholders about the readiness of its artificial intelligence integration. The settlement allows Apple to refocus on its upcoming software cycle without the distraction of protracted litigation.
Corporate Earnings: Mixed Results for Super Micro and Occidental
Super Micro Computer (SMCI) reported a significant beat on the bottom line with an adjusted EPS of 84 cents versus the 63 cents expected. However, the company missed revenue targets, posting $10.24 billion against an estimate of $12.45 billion. The mixed results highlight the supply chain complexities still facing the high-performance server market.
Occidental Petroleum (OXY) delivered a standout performance, reporting adjusted net income of $1.07 billion and adjusted EPS of $1.06, nearly doubling the 64-cent estimate. Despite the earnings beat, the company slightly lowered its full-year production guidance to a range of 1,410 to 1,460 MBOED.
MicroStrategy (MSTR) continued its aggressive Bitcoin acquisition strategy, revealing it now holds 818,334 BTC. The company reported Q1 revenue of $124.3 million, slightly beating the $120 million estimate. The firm's balance sheet remains heavily tied to the volatility of the cryptocurrency market.
Geopolitical Instability in the Middle East
Security concerns in the Strait of Hormuz intensified today following reports from the UKMTO of a maritime incident. In response, the U.S. has reportedly placed military security personnel aboard commercial vessels transiting the region to deter seizures. This move represents a significant escalation in U.S. efforts to protect global energy supply lines.
Diplomatic relations also soured as the Iranian Foreign Ministry accused the UAE of cooperating with the U.S. and Israel against Tehran. While Iran denied UAE accusations that it fired missiles and drones at the Emirates, it stated its "defensive actions" were exclusively targeted at U.S. assets.
Market Wrap and Healthcare Developments
The broader markets finished the day in the green, with the Dow Jones gaining 356.32 points (0.73%) to close at 49,298.22. The S&P 500 rose 0.82% to 7,259.96, while the Nasdaq climbed 1.03% to 25,325.62. The rally was largely fueled by the tech sector's resilience and strong earnings from the energy sector.
In the healthcare space, Pfizer (PFE) is reportedly accelerating the development of its own weight-loss drugs, according to the Wall Street Journal. This move aims to challenge the current market dominance held by Eli Lilly and Novo Nordisk. The entry of a major player like Pfizer could significantly shift the competitive landscape of the lucrative GLP-1 market.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.